Krajina: Spojené štáty
Jazyk: angličtina
Zdroj: NLM (National Library of Medicine)
orlistat (UNII: 95M8R751W8) (orlistat - UNII:95M8R751W8)
Genentech, Inc.
orlistat
orlistat 120 mg
ORAL
PRESCRIPTION DRUG
XENICAL is indicated for obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet. XENICAL is also indicated to reduce the risk for weight regain after prior weight loss. XENICAL is indicated for obese patients with an initial body mass index (BMI) ≥30 kg/m2 or ≥27 kg/m2 in the presence of other risk factors (e.g., hypertension, diabetes, dyslipidemia). Table 1 illustrates body mass index (BMI) according to a variety of weights and heights. The BMI is calculated by dividing weight in kilograms by height in meters squared. For example, a person who weighs 180 lbs and is 5' 5" would have a BMI of 30. XENICAL is contraindicated in: - Pregnancy [see Use in Specific Populations (8.1)] - Patients with chronic malabsorption syndrome - Patients with cholestasis - Patients with known hypersensitivity to XENICAL or to any component of this product Pregnancy Category X XENICAL is contraindicated during pregnancy, because weight loss offers no potential be
XENICAL is a turquoise, hard-gelatin capsule containing pellets of powder. XENICAL 120 mg Capsules: Turquoise, two-piece, No. 1 opaque hard-gelatin capsule imprinted with ROCHE and XENICAL 120 in black ink — bottle of 90 (NDC 0004-0257-52). Storage and Handling Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Keep bottle tightly closed. XENICAL should not be used after the given expiration date.
New Drug Application
XENICAL- ORLISTAT CAPSULE GENENTECH, INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE XENICAL SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR XENICAL XENICAL (ORLISTAT) CAPSULES FOR ORAL USE INITIAL U.S. APPROVAL: 1999 RECENT MAJOR CHANGES Warnings and Precautions (5.1) 08/2016 INDICATIONS AND USAGE XENICAL is a reversible inhibitor of gastrointestinal lipases indicated for obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet. (1) XENICAL is also indicated to reduce the risk for weight regain after prior weight loss. (1) DOSAGE AND ADMINISTRATION One 120-mg capsule three times a day with each main meal containing fat (during or up to 1 hour after the meal). (2) Advise patients to take a nutritionally balanced, reduced-calorie diet that contains approximately 30% of calories from fat. (2) Distribute the daily intake of fat, carbohydrate, and protein over three main meals. (2) Advise patients to take a multivitamin containing fat-soluble vitamins to ensure adequate nutrition. (2) Take the vitamin supplement at least 2 hours before or after the administration of XENICAL, such as at bedtime. (2) For patients receiving both XENICAL and cyclosporine therapy, administer cyclosporine 3 hours after XENICAL. (2) For patients receiving both XENICAL and levothyroxine therapy, administer levothyroxine and XENICAL at least 4 hours apart. (2) DOSAGE FORMS AND STRENGTHS XENICAL 120 mg Capsules. (3) CONTRAINDICATIONS Pregnancy (4, 8.1) Chronic malabsorption syndrome (4) Cholestasis (4) Known hypersensitivity to XENICAL or to any component of this product (4) WARNINGS AND PRECAUTIONS XENICAL has drug interactions and can decrease vitamin absorption. (5.1,7) Take a multivitamin supplement that contains fat-soluble vitamins to ensure adequate nutrition. (5.1) Rare cases of severe liver injury with hepatocellular necrosis or acute hepatic failure have been reported. (5.2) Patients may dev Prečítajte si celý dokument